共 50 条
Osimertinib in EGFR T790M Advanced NSCLC: Analysis of Uncommon/Complex EGFR Mutations in a Real-World Study (ASTRIS)
被引:4
作者:
Cheema, P.
[1
]
Passaro, A.
[2
]
Martin, C.
[3
]
Tiseo, M.
[4
]
Park, K.
[5
]
Chang, G.
[6
,7
,8
]
Hu, Y.
[9
]
Cho, B. C.
[10
]
Miranda, M.
[11
]
Fernandes, A.
[12
]
Freitas, H.
[13
]
机构:
[1] Univ Toronto, Sunnybrook Odette Canc Ctr, William Osler Hlth Syst, Toronto, ON, Canada
[2] European Inst Oncol Irccs, Ieo, Div Thorac Oncol, Milan, Italy
[3] Inst Alexander Fleming, Dept Oncol, Buenos Aires, DF, Argentina
[4] Univ Hosp Parma, Med Oncol Unit, Parma, Italy
[5] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol, Seoul, South Korea
[6] Taichung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan
[7] Taichung Vet Gen Hosp, Fac Med, Sch Med, Taichung, Taiwan
[8] Natl Yang Ming Univ, Taichung, Taiwan
[9] Hubei Canc Hosp, Dept Oncol, Wuhan, Hubei, Peoples R China
[10] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Seoul, South Korea
[11] Astrazeneca, Biometr & Informat Sci, Cambridge, England
[12] Astrazeneca Us, Gaithersburg, MD USA
[13] AC Camargo Canc Ctr, Clin Res Unit, Sao Paulo, Brazil
关键词:
NSCLC;
EGFR;
Osimertinib;
D O I:
10.1016/j.jtho.2019.08.1844
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
P2.14-59
引用
收藏
页码:S854 / S854
页数:1
相关论文